Clin2
NCT07503548Possibly a fitNot yet recruiting

Tributyrin supplements for type 2 diabetes control

Diabete Mellitus

Part of Hormones & metabolism clinical trials.

This trial tests whether a supplement called tributyrin can help improve blood sugar control, reduce inflammation, and lower heart disease risk in people with type 2 diabetes. It may be an option if you have had diabetes for at least a year and have a higher risk of heart problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
60 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You have had type 2 diabetes for at least one year.
  • Your 10-year risk of a heart attack or stroke is 7.5% or higher.
  • Your diabetes and heart medications have been stable for at least 3 months.
  • You are not currently taking GLP-1 agonists or SGLT2 inhibitors (like Ozempic, Jardiance, etc.).
  • You do not have any serious liver, kidney, or digestive conditions.
  • You have not had a heart attack, stroke, or heart surgery in the past.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07463495Recruiting
Testing a supplement called tributyrin for weight and metabolism

This trial tests whether a supplement called tributyrin, which may help with metabolism and weight loss, is safe and effective for people with obesity. You might qualify if you have a BMI between 30 and 45 and are not taking diabetes medications.

Aarhus N
NCT06384313Recruiting
Butyrate supplement for preventing diabetes

This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.

Maastricht, Limburg
NCT06147635Recruiting· Phase 2
Tributyrin for early acute pancreatitis

This trial tests a supplement called tributyrin (related to butyrate) to see if it can help prevent complications from acute pancreatitis when given early after diagnosis. It is for people having their first episode of pancreatitis, not for those with certain causes or weakened immune systems.

Delft, South Holland
NCT04874012Recruiting· Phase 2
Taurine supplement study for blood sugar, fats, and inflammation

This Phase 2 study tests whether taking taurine affects blood sugar control, cholesterol/fats, and inflammation in people with type 2 diabetes. It may help by improving these lab markers, which are linked to long-term health risks.

Porto Alegre, Rio Grande do Sul
NCT06861062Recruiting
Vitamin D and yeast beta-glucan for type 2 diabetes

This trial tests if taking vitamin D3 and yeast beta-glucan supplements can help control blood sugar and lower heart disease risk in people with type 2 diabetes. It may be an option for those who want to see if supplements can improve their diabetes management.

Nanning, Guangxi
NCT07296484Recruiting· Phase 2
Clofutriben for hard-to-control type 2 diabetes

This trial tests a new medication, clofutriben, for people with hard-to-control type 2 diabetes who might also have mild excess of a stress hormone called cortisol. It aims to see if the drug can help lower blood sugar and improve diabetes management.

Chandler, Arizona

Hear when a new Diabete Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.